The inhibitory effects of cordycepin on colon cancer via various mechanisms have been well documented [17,18,19], including the inhibition of colon cancer cell growth after binding to the adenosine A3 receptor (A3R) [20]. Here, ADORA3 is linked to colonic neoplasm.